New Ileostomy Formation and Subsequent Community-onset Acute and Chronic Kidney Disease: A Population-based Cohort Study. Issue 2 (8th August 2021)

• Record Type: Journal Article
• Authors: Smith, Stephen A.; Ronksley, Paul E.; Tan, Zhi; Dixon, Elijah; Hemmelgarn, Brenda R.; Buie, W. Donald; Pannu, Neesh; James, Matthew T.
• Is Part Of: Annals of surgery. Volume 274:Issue 2(2021)
• Page Start: 352
• Page End: 358
• Publication Date: 2021-08-08
• Subjects: acute kidney injury -- chronic kidney disease -- ileostomy; Surgery -- Periodicals; 617.005
• DOI: 10.1097/SLA.0000000000003617
• Languages: English
• ISSNs: 0003-4932

Abstract

Abstract : Supplemental Digital Content is available in the text Abstract : Objective: The aim of this study was to examine relationships between ileostomy formation and subsequent kidney disease. Summary and Background Data: Colonic absorptive capacity loss from ileostomy formation can cause volume depletion and could result in kidney disease Methods: We conducted a population-based cohort study comparing patients who underwent ileostomy formation with or without bowel resection (ileostomy group) to patients who underwent bowel resection without ileostomy formation (reference group). Adjusted odds ratios (aORs) for community-onset acute kidney injury (AKI) within 3 months and new-onset chronic kidney disease (CKD) within 1 year following hospital discharge were determined. Results: Among 19, 889 patients, 4136 comprised the ileostomy group and 15, 753 comprised the reference group; 1350 patients experienced community-onset AKI and 464 developed new-onset CKD. The aOR for community-onset AKI with ileostomy formation was 4.08 [95% confidence interval (CI) = 3.62–4.61] for any stage AKI, 7.08 (95% CI = 5.66–8.85) for stage ≥2 injury, and 7.67 (95% CI = 5.06–11.63) for stage 3 injuries. Community-onset AKI modified associations between ileostomy formation and new-onset CKD ( P = 0.002). Odds of new-onset CKD were increased in the ileostomy group relative to the reference group for patients both with (aOR = 4.99; 95% CI = 3.42–7.28) and without (aOR = 2.45; 95% CI = 1.85–2.23) previous community-onset AKI episodes. In analyses comparing patients that underwent ileostomy formation and subsequent reversal within 1 year to the reference group without ileostomy, the relationship with new-onset CKD was attenuated for patients both with (aOR = 2.49; 95% CI = 1.50–4.12) and without (aOR = 0.97; 95% CI = 0.67–1.40) previous community-onset AKI episodes. Conclusions: Ileostomy formation is strongly associated with subsequent kidney disease. Vigilance for this complication and new strategies for prevention and treatment are necessary.